A new potential nano-oncological therapy based on polyamino acid nanocapsules

Journal of Controlled Release

Volumn 169, Issue 1-2, 2013, Pages 10-16

  Gonzalo, Teresa ^a,d   Lollo, Giovanna ^a,b,e   Garcia Fuentes, Marcos ^a,b   Torres, Dolores ^a   Correa, Juan ^a   Riguera, Ricardo ^a   Fernandez Megia, Eduardo ^a   Calvo, Pilar ^c   Avilés, Pablo ^c   Guillén, Maria José ^c   Alonso, Maria José ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b PharmaMar SA ^*  (Spain)

^c PHARMAMAR S A   (Spain)

^d Ambiox Biotech   (Spain)

^e UNIVERSITÉ D'ANGERS   (France)

Author keywords

Cancer; Long circulating nanocarriers; Nanocapsules; Nanomedicines; Polyglutamic acid

Indexed keywords

CANCER; ENCAPSULATION EFFICIENCY; MAXIMUM TOLERATED DOSE; NANO-CARRIERS; NANOMEDICINES; NEGATIVE ZETA POTENTIALS; POLYGLUTAMIC ACIDS; SOLVENT DISPLACEMENTS;

CARDIOVASCULAR SYSTEM; ENCAPSULATION; TOXICITY; ZETA POTENTIAL;

NANOCAPSULES;

CREMOPHOR; DEHYDRODIDEMNIN B; LIPID; NANOCAPSULE; NANOCARRIER; POLYAMINOACID; POLYGLUTAMIC ACID; SOLVENT;

ANIMAL EXPERIMENT; ARTICLE; CANCER THERAPY; CIRCULATION; CONTROLLED STUDY; DRUG RELEASE; DRUG STABILITY; FREEZE DRYING; IN VIVO STUDY; MOUSE; NANOEMULSION; NANOENCAPSULATION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STATIC ELECTRICITY; STORAGE; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; DEPSIPEPTIDES; MALE; MICE; MODELS, MOLECULAR; NANOCAPSULES; POLYGLUTAMIC ACID;

EID: 84877061402     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.03.037     Document Type: Article

References (40)

1. J.H. Park, S. Lee, J.-H. Kim, K. Park, K. Kim, and I.C. Kwon Polymeric nanomedicine for cancer therapy Prog. Polym. Sci. 33 2008 113 137 (Pubitemid 350278530)
2. H. Gelderblom, J. Verweij, K. Nooter, and A. Sparreboom Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation Eur. J. Cancer 37 2001 1590 1598 (Pubitemid 32778603)
3. E. Blanco, A. Hsiao, A.P. Mann, M.G. Landry, F. Meric-Bernstam, and M. Ferrari Nanomedicine in cancer therapy: innovative trends and prospects Cancer Sci. 102 2011 1247 1252
4. G. Lollo, G. Rivera-Rodriguez, D. Torres, and M.J. Alonso Oncologic nanotherapies: current applications and future perspectives An. Real Acad. Nac. Farm. 77 2011 76 98
5. S.M. Moghimi, and J. Szebeni Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties Prog. Lipid Res. 42 2003 463 478 (Pubitemid 37237636)
6. Y. Malam, M. Loizidou, and A.M. Seifalian Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer Trends Pharmacol. Sci. 30 2009 592 599
7. J. Hrkach, D. Von Hoff, M.M. Ali, E. Andrianova, J. Auer, T. Campbell, D. De Witt, M. Figa, M. Figueiredo, A. Horhota, S. Low, K. McDonnell, E. Peeke, B. Retnarajan, A. Sabnis, E. Schnipper, J.J. Song, Y.H. Song, J. Summa, D. Tompsett, G. Troiano, T. Van Geen Hoven, J. Wright, P. LoRusso, P.W. Kantoff, N.H. Bander, C. Sweeney, O.C. Farokhzad, R. Langer, and S. Zale Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile Sci. Transl. Med. 4 2012 128 139
8. F. Canal, J. Sanchis, and M.J. Vicent Polymer-drug conjugates as nano-sized medicines Curr. Opin. Biotechnol. 22 2011 894 900
9. C. Oerlemans, W. Bult, M. Bos, G. Storm, J.F.W. Nijsen, and W.E. Hennink Polymeric micelles in anticancer therapy: targeting, imaging and triggered release Pharm. Res. 27 2010 2569 2589
10. P. Hervella, G. Lollo, F. Oyarzun-Ampuero, G. Rivera-Rodriguez, D. Torres, and M.J. Alonso Nanocapsules as carriers for the transport and targeted delivery of bioactive molecules T. Trindade, A.L. Daniel, Nanocomposite Particles for Bio-applications: Materials and Bio-interfaces 2011 Pan Stanford Publishing Singapore 350
11. M.V. Lozano, H. Esteban, J. Brea, M.I. Loza, D. Torres, and M.J. Alonso Intracellular delivery of docetaxel using freeze-dried polysaccharide nanocapsules J. Microencapsul. 30 2013 181 188
12. N.T. Huynh, C. Passirani, P. Saulnier, and J.P. Benoit Lipid nanocapsules: a new platform for nanomedicine Int. J. Pharm. 379 2009 201 209
13. M.J. Alonso, and P. Couvreur Historical view of the design and development of nanocarriers for overcoming biological barriers M.J. Alonso, N. Csaba, Nanostructured Biomaterials for Overcoming Biological Barriers 2012 The Royal Society of Chemistry Cambridge UK 3 36
14. N.T. Huynh, E. Roger, N. Lautram, J.-P. Benoît, and C. Passirani The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting Nanomedicine 5 2010 1415 1433
15. D.E. Owens Iii, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102 (Pubitemid 41773257)
16. J.V. González-Aramundiz, M.V. Lozano, A. Sousa-Herves, E. Fernandez-Megia, and N. Csaba Polypeptides and polyaminoacids in drug delivery Expert Opin. Drug Deliv. 9 2012 183 201
17. B.C. Dash, G. Réthoré, M. Monaghan, K. Fitzgerald, W. Gallagher, and A. Pandit The influence of size and charge of chitosan/polyglutamic acid hollow spheres on cellular internalization, viability and blood compatibility Biomaterials 31 2010 8188 8197
18. J.W. Singer Paclitaxel poliglumex (XYOTAX™, CT-2103): a macromolecular taxane J. Control. Release 109 2005 120 126 (Pubitemid 41737258)
19. C. Li, and S. Wallace Polymer-drug conjugates: recent development in clinical oncology Adv. Drug Deliv. Rev. 60 2008 886 898
20. W. Song, M. Li, Z. Tang, Q. Li, Y. Yang, H. Liu, T. Duan, H. Hong, and X. Chen Methoxypoly(ethylene glycol)-block-poly(l-glutamic acid)-loaded cisplatin and a combination with iRGD for the treatment of non-small-cell lung cancers Macromol. Biosci. 12 2012 1514 1523
21. Y. Bae, and K. Kataoka Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers Adv. Drug Deliv. Rev. 61 2009 768 784
22. M. Morille, T. Montier, P. Legras, N. Carmoy, P. Brodin, B. Pitard, J.P. Benoit, and C. Passirani Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting Biomaterials 31 2010 321 329
23. M.J. Muñoz-Alonso, T. Martínez, A. Losada, C.M. Galmarini, and A. Muñoz The mechanism of action of plitidepsin Curr. Opin. Investig. Drugs 10 2009 536 542
24. P. Calvo, C. Remuñán-López, J. Vila-Jato, and M. Alonso Development of positively charged colloidal drug carriers: chitosan-coated polyester nanocapsules and submicron-emulsions Colloid Polym. Sci. 275 1997 (46-53-53)
25. P. Avilés, M.J. Guillén, P.Calvo, M.J. Alonso, D. Torres, M. García Fuentes, T. Gonzalo, Lollo G., Nanocapsules for use in pharmaceutical compositions (EP11382003.9)
26. E.F.A. Brandon, R.D. van Ooijen, R.W. Sparidans, L.L. Lázaro, A.J.R. Heck, J.H. Beijnen, and J.H.M. Schellens Structure elucidation of aplidine metabolites formed in vitro by human liver microsomes using triple quadrupole mass spectrometry J. Mass Spectrom. 40 2005 821 831 (Pubitemid 40905248)
27. B. Romberg, J.M. Metselaar, L. Baranyi, C.J. Snel, R. Bünger, W.E. Hennink, J. Szebeni, and G. Storm Poly(amino acid)s: promising enzymatically degradable stealth coatings for liposomes Int. J. Pharm. 331 2007 186 189 (Pubitemid 46223617)
28. K. Knop, R. Hoogenboom, D. Fischer, and U.S. Schubert Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives Angew. Chem. Int. Ed. 49 2010 6288 6308
29. M.V. Lozano, D. Torrecilla, D. Torres, A. Vidal, F. Dominguez, and M.J. Alonso Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers Biomacromolecules 9 2008 2186 2193
30. C. Kusonwiriyawong, K. Atuah, O.H. Alpar, H.P. Merkle, and E. Walter Cationic stearylamine-containing biodegradable microparticles for DNA delivery J. Microencapsul. 21 2004 25 36 (Pubitemid 38180745)
31. S. Barbault-Foucher, R. Gref, P. Russo, J. Guechot, and A. Bochot Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery J. Control. Release 83 2002 365 375 (Pubitemid 35223259)
32. M. Garcia-Fuentes, D. Torres, M. Martín-Pastor, and M.J. Alonso Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles Langmuir 20 2004 8839 8845
33. C.E. Mora-Huertas, H. Fessi, and A. Elaissari Polymer-based nanocapsules for drug delivery Int. J. Pharm. 385 2010 113 142
34. R. Gref, A. Domb, P. Quellec, T. Blunk, R.H. Müller, J.M. Verbavatz, and R. Langer The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres Adv. Drug Deliv. Rev. 16 1995 215 233
35. V. Torchilin Tumor delivery of macromolecular drugs based on the EPR effect Adv. Drug Deliv. Rev. 63 2011 131 135
36. A.O. Nornoo, and D.S.L. Chow Cremophor-free intravenous microemulsions for paclitaxel: II. Stability, in vitro release and pharmacokinetics Int. J. Pharm. 349 2008 117 123 (Pubitemid 350299696)
37. S.-W. Lee, M.-H. Yun, S.W. Jeong, C.-H. In, J.-Y. Kim, M.-H. Seo, C.-M. Pai, and S.-O. Kim Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system J. Control. Release 155 2011 262 271
38. L. Wang, Z. Liu, D. Liu, C. Liu, Z. Juan, and N. Zhang Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity Int. J. Pharm. 413 2011 194 201
39. L. Zhang, Y. He, G. Ma, C. Song, and H. Sun Paclitaxel-loaded polymeric micelles based on poly(É-caprolactone)-poly(ethylene glycol)- poly(É-caprolactone) triblock copolymers: in vitro and in vivo evaluation Nanomed. Nanotechnol. Biol. Med. 8 2012 925 934
40. F.K. Engels, R.A.A. Mathot, and J. Verweij Alternative drug formulations of docetaxel: a review Anti Cancer Drugs 18 2007 95 103 (Pubitemid 44967420)